Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020

SELL
$16.5 - $29.7 $503,662 - $906,592
-30,525 Closed
0 $0
Q1 2020

May 04, 2020

SELL
$13.68 - $34.6 $53,912 - $136,358
-3,941 Reduced 11.43%
30,525 $545,000
Q4 2019

Feb 06, 2020

BUY
$21.11 - $34.86 $82,434 - $136,128
3,905 Added 12.78%
34,466 $1.15 Million
Q4 2019

Feb 04, 2020

SELL
$21.11 - $34.86 $51,803 - $85,546
-2,454 Reduced 7.43%
30,561 $899,000
Q3 2019

Nov 12, 2019

BUY
$23.83 - $36.44 $766,420 - $1.17 Million
32,162 Added 3770.46%
33,015 $787,000
Q4 2018

Feb 05, 2019

SELL
$38.35 - $50.39 $6,212 - $8,163
-162 Reduced 15.96%
853 $37,000
Q3 2018

Nov 01, 2018

BUY
$41.65 - $51.7 $42,274 - $52,475
1,015 New
1,015 $48,000

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $260M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.